Biogenes Technologies is trying to change the biotech landscape by creating and commercialising synthetic antibodies for mass use in all kinds of test kits. However building and scaling a deeptech startup like this can be challenging here in Malaysia without the right help.
We speak to Adrian Joseph, Co-Founder & Chief Commercial Officer, of Biogenes Technologies about the startup’s journey and mission, and how Cradle Fund has supported them along the way.

Baking Cakes That Actually Taste As Good As They Look
27:39

Why Investors Just Put RM10M Into This Malaysian Accounting School
32:42

Inside Malaysia's Multi-Million Ringgit Preschool Empire
25:40